Similar articles

• Recent progress in the treatment of hepatocellular carcinoma.

  Roh MS. Roh MS. Curr Opin Oncol. 1990 Aug;2(4):725-30. Curr Opin Oncol. 1990. PMID: 1965691 Review. No abstract available.
• Iodine-131-Lipiodol for hepatocellular carcinoma: the benefits of targeting.

  Novell JR, Hilson AJ. Novell JR, et al. J Nucl Med. 1994 Aug;35(8):1318-20. J Nucl Med. 1994. PMID: 8046486 No abstract available.
• Radiation therapy in liver cancer.

  Glimelius B. Glimelius B. Ann Chir Gynaecol Suppl. 1986;200:75-8. Ann Chir Gynaecol Suppl. 1986. PMID: 3014991 Review. No abstract available.
• Radiolabeled antibody therapy.

  Bucholtz JD. Bucholtz JD. Semin Oncol Nurs. 1987 Feb;3(1):67-73. doi: 10.1016/s0749-2081(87)80085-2. Semin Oncol Nurs. 1987. PMID: 3031793 Clinical Trial. No abstract available.
• [A 42-month disease free survival case of combined hepatocellular-cholangiocarcinoma with lymph node metastases treated with multimodal therapy].

  Hayashi H, Beppu T, Ishiko T, Mizumoto T, Masuda T, Okabe K, Baba Y, Okabe H, Takamori H, Kanemitsu K, Hiroto M, Baba H. Hayashi H, et al. Gan To Kagaku Ryoho. 2006 Nov;33(12):1941-3. Gan To Kagaku Ryoho. 2006. PMID: 17212153 Japanese.